HIV遗传多样性可推断博茨瓦纳接受抗逆转录病毒治疗患者的HIV-1感染阶段
研究基于博茨瓦纳1944名已知感染时长的参与者,利用前病毒DNA全基因组测序和机器学习模型,根据病毒遗传多样性、病毒载量、年龄、性别和ART状态区分感染是否超过1年,平衡准确率达90.6%(95%CI 86.7%-94.1%),且在多数接受ART的患者中仍有效。
要点
- 基于gag、pol、env遗传多样性及临床变量的模型可区分HIV-1感染是否超过1年。
- 模型平衡准确率为90.6%(95%CI 86.7%-94.1%),多数参与者接受ART。
- 即使病毒被抑制,仍可通过病毒序列多样性推断感染近期性。
核心结论
- 即使患者接受抑制性ART,仍可通过HIV-1病毒序列多样性推断感染的近期性。
研究设计与样本
- 从博茨瓦纳队列中纳入1944名基于重复检测估计HIV-1感染时长的参与者,从前病毒DNA进行全基因组测序,优化机器学习模型分类感染是否超过1年。
主要发现
- 最佳预测模型包含HIV-1 gag、pol和env遗传多样性、病毒载量、年龄、性别和ART状态等变量。
- 模型平衡准确率为90.6%(95%CI 86.7%-94.1%),多数参与者接受ART。
- 在新诊断参与者中,自报1年内HIV检测阴性者比自报超过1年者更常被分类为近期感染。
- 自报1年内HIV检测阴性者无论是否有记录,分类无差异。
关键数值与推荐
- 模型分类感染是否超过1年的平衡准确率为90.6%(95%CI 86.7%-94.1%)。
临床怎么用
- 可利用病毒序列多样性辅助判断HIV-1感染近期性,尤其在接受抑制性ART的患者中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus (HIV)-1 genetic diversity increases during infection and can help infer the time elapsed since infection. However, the effect of antiretroviral treatment (ART) on the inference remains unknown. METHODS: Participants with estimated duration of HIV-1 infection based on repeated testing were sourced from cohorts in Botswana (n = 1944). Full-length HIV genome sequencing was performed from proviral deoxyribonucleic acid. We optimized a machine learning model to classify infections as < or >1 year based on viral genetic diversity, demographic, and clinical data. RESULTS: The best predictive model included variables for genetic diversity of HIV-1 gag, pol, and env, viral load, age, sex, and ART status. Most participants were on ART. Balanced accuracy was 90.6% (95% confidence interval, 86.7%-94.1%). We tested the algorithm among newly diagnosed participants with or without documented negative HIV tests. Among those without records, those who self-reported a negative HIV test within <1 year were more frequently classified as recent than those who reported a test >1 year previously. There was no difference in classification between those self-reporting a negative HIV test <1 year, whether or not they had a record. CONCLUSIONS: These results indicate that recency of HIV-1 infection can be inferred from viral sequence diversity even among patients on suppressive ART.
引用
- Ragonnet-Cronin M, Golubchik T, Moyo S, et al. Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana. J Infect Dis. 2022. PMID: 34077517. doi:10.1093/infdis/jiab293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。